Comparison between therapeutic antitoxin F(ab)2 fractionated with amonium sulfate and caprylic acid

Journal of Immunoassay and Immunochemistry

Volumn 27, Issue 4, 2006, Pages 319-329

  Redwan, El Rashdy M ^a,b  

^a GENETIC ENGINEERING AND BIOTECHNOLOGY RESEARCH INSTITUTE   (Egypt)

^b Universities and Research centers District   (Egypt)

Author keywords

Ammonium sulfate; Anti complementary; Caprylic Acid; Fractionation protocols; Horse F(ab)2 antibody; Impurities

Indexed keywords

AMMONIUM SULFATE; ANTITOXIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; OCTANOIC ACID;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; NEISSERIA MENINGITIDIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TOXIN ANALYSIS;

AMMONIUM SULFATE; ANTIGEN-ANTIBODY REACTIONS; ANTITOXINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRACTIONAL PRECIPITATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LIPOPOLYSACCHARIDES; OCTANOIC ACIDS; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 33747091599     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810600861993     Document Type: Article

References (17)

1. Sutherland, S.K. Serum reactions: an analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins. Med. J. Aust. 1977, 1 (17), 613-615.
2. Malasit, P.; Warrell, D.A.; Chanthavanich, P.; Viravan, C.; Mongkolsapaya, J.; Singhthong, B.; Supich, C. Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. Br. Med. J. 1986, 292 (6512), 17-20.
3. 2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon 2001, 39 (6), 793-801.
4. Lalloo, D.G. Theakston. R.D.G. Snake antivenoms. J. Toxicol. Clin. Toxicol. 2003, 41 (3), 277-290.
5. Theakston, R.D.G.; Warrella, D.A.; Griffiths, B.E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003, 41 (5), 541-557.
6. Rojas, G.; Jimenez, J.M.; Gutterrez, J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of simple procedure for antivenom production. Toxicon 1994, 32 (3), 351-363.
7. Gene, J.A.; Roy, A.; Rojas, G.; Gutierez, J.M.; Cerdas, L. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenlytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 1989, 27 (8), 841-848.
8. Otero, R.; Gutierrez, J.M.; Rojas, G.; Nunez, V.; Dýaz, A.; Miranda, E.; Uribe, A.F.; Silva, J.F.; Ospina, J.G.; Medina, Y.; Toro, M.F.; Garcýa, M.E.; Leon, G.; Garcýa, M.; Lizano, S.; De La Torre, J.; M'arquez, J.; Mena, Y.; Gonzalez, N.; Arenas, L.C.; Puzon, A.; Blanco, N.; Sierra, A.; Espinal, M.E.; Arboleda, M.; Jim'enez, J.C.; Ramýrez, P.; Dýaz, M.; Guzman, M.C.; Barros, J.; Henao, S.; Ramýrez, A.; Macea, U.; Lozano, R. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 1999, 37 (6), 895-908.
9. Gutierrez, J.M.; Rojas, E.; Quesada, L.; Leon, J.; Nunez, J.; Laing, G.D.; Sasa, M.; Renjifo, J.M.; Nasidi, A.; Warrell, D.A.; Theakston, R.D.G.; Rojas, G. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans. Roy. Soc. Trop. Med. Hyg. 2005, 99 (8), 468-475.
10. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227 (5259), 680-685.
11. Redwan, E.M. Biochemical and immunological properties of four intravenous immunoglobulin G preparations. Hum Antibody 2002, 11 (3), 79-84.
12. Petsch, D.; Anspach, F.B. Endotoxin removal from protein solutions. J. Biotechnol. 2000, 76 (2-3), 97-119.
13. Sharma, S.K. Endotoxin detection and elimination in biotechnology. Biotechnol. Appl. Biochem. 1986, 8 (1), 5-22.
14. Silva de Freitas, S.; Machadoa, R.L.; José de Arruda, E.; Santana, C.C.; Alves Buenoa, S. Endotoxin removal from solutions of F(ab)2 fragments of equine antibodies against snake venom using macroporous chitosan membrane. J. Membr. Sci. 2004, 234, 67-73.
15. Ramasamy, I.; Tran, E.; Farrugia, A. Measurement of anticomplementary activity in therapeutic intravenous immunoglobulin preparations. Biologicals 1997, 25 (1), 87-92.
16. Chippaux, J.P. The development and use of immunotherapy in Africa. Toxicon 1998, 36 (11), 1503-1506.
17. Leon, G.; Lomonte, B.; Gutierrez, J.M. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 2005, 45 (1), 123-128.